Palvella Therapeutics (PVLA) Change in Acquisitions & Divestments (2018 - 2024)

Palvella Therapeutics (PVLA) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $9.0 million in Q1 2024.

• On a quarterly basis, Change in Acquisitions & Divestments fell 33.31% year-over-year to $9.0 million in Q1 2024; TTM through Sep 2024 was $20.0 million, a 34.01% decrease from a year earlier, with the FY2023 full-year figure at $35.0 million, up 24.14% from the prior year.
• Change in Acquisitions & Divestments for Q1 2024 stood at $9.0 million, down from $11.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for PVLA reached as high as $28.4 million in Q1 2020 and fell as low as $4.8 million in Q2 2022.
• Historically, Change in Acquisitions & Divestments has averaged $13.0 million across 4 years, with a median of $12.2 million in 2023.
• Across the five-year window, Change in Acquisitions & Divestments surged 898.35% in 2020 and slumped 70.02% in 2023, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $15.8 million in 2020, then slumped by 60.0% to $6.3 million in 2022, then jumped by 74.62% to $11.0 million in 2023, then fell by 18.19% to $9.0 million in 2024.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $9.0 million in Q1 2024, $11.0 million in Q4 2023, and $5.1 million in Q3 2023.